Upgrade to SI Premium - Free Trial

OncoCyte (OCX) Misses Q3 EPS by 98c

November 12, 2024 10:45 PM

OncoCyte (NASDAQ: OCX) reported Q3 EPS of ($0.98). Revenue for the quarter came in at $110 thousand.

For earnings history and earnings-related data on OncoCyte (OCX) click here.

Categories

Earnings